NFKB1 and breast cancer: The activation of the non-canonical NF-κB pathway by NIK upregulation contributes to the enhancement of cell proliferation and maintenance of cancer stemness properties via the NOTCH pathway, especially in basal-like breast cancer cell lines [19, 40].